LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 41 filers reported holding LUMOS PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $299,620 | +15.9% | 90,794 | +15.9% | 0.13% | +14.5% |
| Q2 2023 | $258,558 | +52.6% | 78,351 | +53.0% | 0.12% | +67.1% |
| Q1 2023 | $169,489 | -76.8% | 51,205 | 0.0% | 0.07% | -32.7% |
| Q4 2022 | $732,000 | 0.0% | 51,205 | 0.0% | 0.10% | -35.4% |
| Q3 2022 | $732,000 | 0.0% | 51,205 | 0.0% | 0.16% | +94.0% |
| Q2 2022 | $732,000 | +52.2% | 51,205 | 0.0% | 0.08% | -25.9% |
| Q1 2022 | $481,000 | +35.9% | 51,205 | 0.0% | 0.11% | +17.9% |
| Q4 2021 | $354,000 | -90.9% | 51,205 | -87.4% | 0.10% | -86.9% |
| Q3 2021 | $3,872,000 | -4.9% | 407,192 | 0.0% | 0.73% | +3.1% |
| Q2 2021 | $4,071,000 | -14.5% | 407,192 | 0.0% | 0.70% | -18.8% |
| Q1 2021 | $4,764,000 | -67.2% | 407,192 | 0.0% | 0.87% | -69.0% |
| Q4 2020 | $14,540,000 | +158.4% | 407,192 | 0.0% | 2.80% | +126.9% |
| Q3 2020 | $5,627,000 | -16.2% | 407,192 | 0.0% | 1.23% | -24.2% |
| Q2 2020 | $6,714,000 | +94.0% | 407,192 | 0.0% | 1.63% | +78.3% |
| Q1 2020 | $3,461,000 | – | 407,192 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acuitas Investments, LLC | 153,867 | $507,761 | 0.30% |
| Lion Point Capital, LP | 78,351 | $258,558 | 0.12% |
| Minerva Advisors LLC | 26,549 | $84 | 0.06% |
| Wealth Advisors of Iowa, LLC | 11,699 | $38,606 | 0.03% |
| Marquette Asset Management, LLC | 31,088 | $102,591 | 0.02% |
| Greenwich Wealth Management LLC | 49,002 | $162 | 0.02% |
| Key FInancial Inc | 10,927 | $36,059 | 0.01% |
| Paladin Advisory Group, LLC | 4,387 | $14,477 | 0.01% |
| Blackstone Inc. | 468,145 | $1,544,879 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $157,222 | 0.00% |